Pharma lashes out at the Netherlands over drug pricing policies - STAT

Pharma lashes out at the Netherlands over drug pricing policies - STAT

More reads

• Pharma lashes out at the Netherlands over drug pricing policies. (STAT Plus)
• New CRISPR fight: Old friends Intellia, Caribou in license dispute. (Xconomy)
• Alphabet's Verily is building a high-tech rehab campus to combat opioid addiction. (CNBC)
• Macrogenics offers major surprise with positive breast cancer data, as shares double. (STAT Plus)